Benefit of early treatment in inflammatory polyarthritis patients with anti–cyclic citrullinated peptide antibodies versus those without antibodies

OBJECTIVE: To compare the clinical utility of anti–cyclic citrullinated peptide (anti-CCP) antibodies and rheumatoid factor (RF) testing in predicting both functional outcome and response to treatment in early inflammatory polyarthritis (IP) patients. METHODS: A total of 916 IP subjects from a prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Farragher, Tracey M, Lunt, Mark, Plant, Darren, Bunn, Diane K, Barton, Anne, Symmons, Deborah P M
Formato: Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2010
Materias:
Inflammatory Polyarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962800/
https://www.ncbi.nlm.nih.gov/pubmed/20461787
http://dx.doi.org/10.1002/acr.20207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962800/
https://www.ncbi.nlm.nih.gov/pubmed/20461787
http://dx.doi.org/10.1002/acr.20207

Ejemplares similares